Vera Therapeutics (VERA) Long-Term Deferred Tax (2023)

Vera Therapeutics (VERA) has 3 years of Long-Term Deferred Tax data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, changed N/A from the prior year.
• Long-Term Deferred Tax declined to $2.0 million in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.5 million in Q4 2025 to a low of $719000.0 in Q4 2023.
• A 3-year average of $1.7 million and a median of $2.0 million in 2026 frame the typical range for Long-Term Deferred Tax.